|
|
Volumn 65, Issue SUPPL. 1, 2006, Pages
|
|
Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ERLOTINIB;
GEFITINIB;
IMATINIB;
MITOGEN ACTIVATED PROTEIN KINASE;
PERILLYL ALCOHOL;
PROTEIN TYROSINE KINASE INHIBITOR;
RAS PROTEIN;
TIPIFARNIB;
CARCINOGENESIS;
CELL ADHESION;
CELL MIGRATION;
CHROMOSOME DELETION;
CLINICAL TRIAL;
DRUG INHIBITION;
GLIOBLASTOMA;
GLIOMA CELL;
HUMAN;
MOLECULAR GENETICS;
NOTE;
PHENOTYPE;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 30944451546
PISSN: 00903019
EISSN: None
Source Type: Journal
DOI: 10.1016/j.surneu.2005.07.013 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
